Mobile Site ›

Print Friendly View

Unit Code 88878:
Alpha-Fetoprotein (AFP) L3% and Total, Hepatocellular Carcinoma Tumor Marker, Serum

Useful For Suggests clinical disorders or settings where the test may be helpful

Distinguishing between hepatocellular carcinoma and chronic liver

disease

 

Monitoring individuals with hepatic cirrhosis from any etiology for

progression to hepatocellular carcinoma

 

Surveillance for development of hepatocellular carcinoma in

individuals with a positive family history of hepatic cancer

 

Surveillance for development of hepatocellular carcinoma in

individuals within specific ethnic and gender groups who do not

have hepatic cirrhosis, but have a confirmed diagnosis of chronic

infection by hepatitis B acquired early in life including:

 - African males above the age of 20

 - Asian males above the age of 40

 - Asian females above the age of 50

Method Name A short description of the method used to perform the test

Immunoenzymatic/Liquid Phase Binding

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

AFP-L3% and Total AFP, S

Ordering Mnemonic An alternate Mayo code (to the Unit Code) for a test

L3AFP

Aliases Lists additional common names for a test, as an aid in searching

Soft-L3AFP